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Summary 
Normal human bone marrow, cultured in vitro with interleukin 5 to promote eosinophil production 
and maturation,  was inoculated with cell-free isolates of human immunodeficiency virus type 
1 (HIV-1). CD4 expression by eosinophil precursors, determined by immunocytochemistry, was 
found to be greatest early in their maturation with a rapid decline after 28 d in culture. Productive 
HIV infection of eosinophil precursors was detected 14 d  after inoculation,  by a combination 
of immunostaining for HIV-1 p24 and gp41/160 and in situ hybridization for viral RNA, together 
with assay of culture supernatants for p24 antigen and reverse transcriptase activity. Thus, eosinophils 
are susceptible to productive HIV-1 infection in vitro and may be an important  reservoir for 
the virus in vivo. 
H 
uman immunoddidency viruses (HIV-1 and HIV-2) are 
known to infect in vivo cells bearing the CD4 glyco- 
protein surface receptor (1). These indude both T helper lym- 
phocytes and also cells of the monocyte/macrophage series. 
Infection of these cells is believed to be the major cause of 
immune deficiency seen in the later stages of HIV infection. 
However, several other cell types are known to express mem- 
brane CD4 and are, therefore, potential targets for HIV in- 
fection. For example, eosinophils isolated from peripheral blood 
of patients with eosinophilia have been shown to express CD4 
on their surface,  to which HIV-1 gp 120 will bind in vitro 
(2), although HIV infection of these cells has not previously 
been reported. 
Eosinophils are granulocytic leukocytes derived from bone 
marrow stem cells and, like macrophages, they migrate rap- 
idly from peripheral blood into tissues, where they may sur- 
vive for several weeks (3). Although in vivo functions of eo- 
sinophils are not fully understood,  their numbers,  both in 
blood and tissues,  increase greatly in response to parasitic in- 
fections (4). Thus, the possibility that eosinophils are infected 
by HIV in vivo would have important  implications for the 
pathogenesis of HIV disease,  particularly in tropical coun- 
tries where both HIV and parasitic infections are widespread. 
For this reason we have investigated  the potential  for eo- 
sinophils to support HIV infection by attempting to infect 
normal human eosinophil precursors with HIV-1 strains in 
vitro. 
Materials  and Methods 
Bone Marrow Culture and Infection with HIVI.  Normal human 
bone marrow samples were obtained, with informed consent, from 
five  healthy  volunteers  by iliac  crest  aspiration.  Mononuclear cells 
were separated by centtifugation over HcoH  and suspended in IMDM 
containing  15% FCS, at 10  ~ cells/ml. Human rlL-5 (Glaxo Group 
Research Ltd., Greenford, UK) was added at 2 ng/ml to promote 
eosinophil differentiation (5). Cells were cultured  for up to 56 d 
in 96-well microtitre  plates (I(P cells in 100/~l/well),  at 37~  in 
95% air/5% COs. To infect the cultured cells with HIV, cell-free 
supernatants of the R.F, RUT, and IIIB strains of HIV-1 (MILC 
AIDS Directed Programme) were added at a concentration  of 104 
tissue culture infectious doses (TCtD)/ml, 7-21 d after the start 
of the cultures. 
Detection of  Eosinophil CD4, HIV Antigens, and RNA.  Antigen 
expression by the maturing eosinophil precursors was detected by 
immunostaining  of cytospin slides prepared at 7-d intervals, using 
the alkaline phosphatase anti-alkaline phosphatase technique with 
fast red substrate and hematoxylin counterstain (6). Separate slides 
at each time-point  were stained with mAbs to CD4 (Dakopatts, 
High Wycombe, UK), and HIV p24 core protein  (MRC EH12) 
and gp41/160 envelope glycoprotein  (MtLC ADP330).  The per- 
centage of maturing eosinophils expressing CD4 was determined 
as a function of time in control, uninfected cultures by examining 
100 cells on each slide. CD4 expression was quantitated by scoring 
each cell on an arbitrary scale from 0 to 3 according to the intensity 
of staining by anti-CD4 antibody. HIV-1 RNA was detected in 
infected cells by in situ hybridization  using  a specific 3sS-DNA 
probe  (BH10),  with  carbol  chromotrope  treatment  to  block 
nonspecific staining of eosinophils (7). 
Detection of ViralReI~lication.  50-/zl  aliquots of culture superna- 
tant was removed from each well at weekly intervals and replaced 
with fresh medium. Supernatants were stored at  - 70~  and sub- 
sequently assayed  for reverse transcriptase (KT) activity (8), for HIV 
p24 antigen level  measured by F.LISA  (Coulter Immunology, l.uton, 
UK) and for infectivity, assessed  by coculture with Jurkat T cells. 
Supematants  from the cocultures were assayed for I~T activity at 
dayS. 
1661  J. Exp. Med. ￿9  The Rockefeller  University Press ￿9 0022-1007/91/12/1661/04 $2.00 
Volume 174  December 1991  1661-1664 ~eSll|tS 
Bone Marrow Culture and Eosinophil CD4 Expression.  After 
21 d  in culture,  >95%  of surviving  calls were eosinophil 
precursors. These ceils developed gradually from early pro- 
myelocytes seen at  day  7,  through to  mature,  terminally 
differentiated  eosinophils after 56 d in culture, as assessed  mor- 
phologically. CD4 expression by control, uninfected  eosino- 
phil precursors was maximal in terms of  both percentage and 
intensity during the first 28 d in culture, with a gradual de- 
cline to almost  undetectable  levels by 56 d  (Fig. 1). 
HIV Antigen and RNA Expression by Eosinophils.  Fig. 2 
shows a 35-d-old culture,  21 d after infection  with HIV-1 
ILF strain,  stained as described above for p24 antigen. In- 
fected eosinophils expressed p24 predominantly on their cell 
membrane and a similar pattern was observed when stained 
for gp41/160.  In situ hybridization confirmed the presence 
of HIV RNA in infected eosinophils (Fig. 3). Control, unin- 
fected cultures were negative for both HIV antigen and RNA 
expression (not shown). Eosinophil precursors first showed 
evidence  of  infection 14 d after the addition of viral inoculum. 
A maximum of 4% of the cells stained positively for either 
antigen or RNA. Infection of eosinophils was observed in 
two cultures infected with HIV-1 RF strain and one with 
Figure 1.  CD4 expression by uninfected  eosinophil  precursors in cul- 
ture. Normal human bone marrow was cultured in the presence of IbS, 
and CD4 expression was assessed at weekly intervals by staining cytospin 
slides with anti-CD4 mAbs. (~p) The percentage of maturing eosinophils 
expressing CD4 plotted against days in culture.  The CD4 score (bottom) 
was derived by scoring 100 cells at each time-point on a scale from 0 to 
3 according  to  the intensity of staining. 
Figure 2.  P24 antigen expression by 
HIV-1 RF-infected eosinophils. Normal 
human bone marrow was cultured in 
the presence of Ib5 and inocuhted with 
HIV-1 RF supernatant  after 14 d. Cells 
were harvested  21 d later  and  stained 
with anti-p24 mAbs using the APAAP 
technique  with  fast  red  substrate  to 
stain positive calls red. An infected eo- 
sinophil  is shown in the center of the 
picture. 
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HIV-1 RF-infected  eosinophils.  Normal 
human bone marrow was cultured in 
the presence  of IL-5  and inoculated  with 
HIV-1 RF supernatant  after  14 d. Cells 
were harvested  14 d later and subjected 
to in situ hybridization  with 35S-DNA 
HIV-1 probe (BH10) as described. Two 
infected  eosinophils  are shown  together 
with uninfected  cells. 
HIVol RUT, but in neither of two cultures inoculated with 
HIV-1  IIIB. 
Viral Replication.  Productive infection of eosinophil cul- 
tures was confirmed by rising levels of IKT activity in the 
supernatant, beginning 7 d after viral inoculation and con- 
tinuing up to 49 d after inoculation, by which time all sur- 
viving eosinophils were morphologically mature (Fig. 4). No 
RT activity was detected in control culture supernatant. Par- 
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IKT activity  in eosinophil  culture supernatant  after infection  Figure 4. 
with HIV-1. Normal human  bone marrow  was cultured  in the presence 
of 1I.-5 and inoculated  with HIV-1 RF supernatant after 14 d. Culture 
supernatant was withdrawn at weekly  intervals and assayed  for RT ac- 
tivity as described. RT activity  (cpm/ml) is plotted against days  after  in- 
oculation. 
aUel rises  in p24  antigen levels were found in the infected 
culture supernatants (data not shown). Jurkat cocuhure ex- 
periments confirmed the presence  of infectious virus in the 
supernatants for up to 42  d  after infection. 
Discussion 
These studies have shown for the first time that eosinophils 
can be infected by HIV-1  and support active replication of 
the virus, thus extending the work of Lucey et al.  (2).  We 
chose to use Ib5-stimulated bone marrow cultures as a source 
of actively dividing eosinophil precursors,  in view of the 
difficulties associated with obtaining purified peripheral blood 
eosinophils from normal individuals in sufficient  quantities 
(9).  We carried out preliminary experiments on peripheral 
blood eosinophils isolated from hyper-eosinophilic subjects, 
but were unable to infect such cells with HIV or to transfect 
them with HIV-LTR CAT constructs. In addition, the pres- 
ence of IL-5 in the culture medium has been found to activate 
eosinophils (10, 11) and, by analogy with macrophages (12), 
this would be expected to enhance HIV replication within 
them. 
We found that CD4 expression by eosinophil precursors 
was greatest early in their maturation, with only very weak 
expression after 28 d in culture. This decline in CD4 expres- 
sion occurred in the absence of HIV which, itself, is known 
to downregulate CD4 expression  on infected cells (13). We, 
therefore, inoculated the cultures with HIV within the first 
21 d in order to maximize the chance of achieving infection, 
although in vitro infection by HIV-1 of a purified CD34 +  / 
CD4-  myeloid progenitor population has been reported (14, 
15), suggesting that CD4 expression may not be necessary. 
Although only up to 4% of eosinophils in culture expressed 
1663  Freedman  et al.  Brief  Definitive Report HIV antigens or RNA, none of the other contaminating cells, 
which comprised <5% of the total, were infected, confirming 
that the viral  activity detected in the culture supernatants 
was due to viral replication within eosinophils.  Typical bi- 
lobed nuclear morphology was observed  in all eosinophils 
after day 49 in culture. The increase in RT and p24 activity 
within the culture supernatant between days 49 and 63 in 
culture (days 35-49  after inoculation) provides  strong evi- 
dence of continuing HIV replication in such mature cells. 
The ability of RF and RUT, but not 11113, strains of HIV-1 
to infect eosinophils suggests that, as for macrophages (16) 
and megakaryocytes (17), there may be strains of HIV with 
tropism for eosinophils.  The latter is a laboratory adapted 
T  lymphocyte tropic strain, which failed to infect CD34 § 
myeloid precursors  in vitro (15). 
Eosinophils are known to have many similarities  to mac- 
rophages, including their tropism for the skin and mucosal 
tissues  and their activation by cytokines (18). Like macro- 
phages,  they may also be a major reservoir for HIV, but fur- 
ther studies will be required to elucidate their role in vivo. 
We thank Glaxo Group Research Ltd. (Greenford, UK) for the gift of recombinant human II.-5, Dr. 
S. Patterson (CRC, Harrow, UK) for the HIV-1 BH10 probe, and the MRC ADP for the supply of HIV-1 
isolates, mAbs and p24 antigen assay kits. We thank Dr. Gary Nabel for helpful discussion and advice. 
This work was supported by a grant from the Medical Research Council AIDS Directed Programme 
(MRC ADP). G. E. Gri~n acknowledges support from the Wellcome Trust, F. M. Gibson is supported 
by the Marrow Environment Fund, and C. J. Spry by the British Heart Foundation. 
Address correspondence  to Andrew Freedman, Division of Communicable Diseases, St. George's Hospital 
Medical School, London SW17 ORE, UK. 
Received for publication 22 July  199I  and in revised form  19 September I991. 
1.  Dalgleish, A.G., C.L. Beverley,  P.R. Clapham, M. Crawford, 
F. Greaves, and R.A. Weiss. 1984. The CD4 (T4) antigen is 
an essential component of the receptor for AIDS retrovirus. 
Nature (Lond.). 312:763. 
2.  Lucey,  D.R., D.I. Dorsky, A. Nicholson-Weller,  and P.E WeUer. 
1989. Human eosinophils  express CD4 protein and bind human 
immunodeficiency virus 1 gp120, j. Ex  F Med. 169:327. 
3.  Sheff, D.M., W.F. Owen, Jr., and K.F. Austen. 1991. Eosino- 
phil phenotypes and LTC4 generation in vitro and in hyper- 
eosinophilic states. Adv. Prostaglandin Thromboxane Leuleotriene 
Res. 21B:481. 
4.  Conrad, M.E. 1971. Hematologic manifestations of parasitic 
infections. Strain. Hematol. 8:267. 
5.  Clutterbuck,  E.J., E.M.A. Hirst, and C.J. Sanderson. 1989. 
Human interleukin-5 (IbS) regulates the production of eo- 
sinophils in human bone marrow cultures: comparison and in- 
teraction with IIA, 11,-3, Ib6, and GMCSF. Blood. 73:1504. 
6.  Cordell, J., B. Falini, W. Erber, A. Ghosh, Z. Abdulaziz, S. 
Macdonald, K. Pulford, H. Stein, and D. Mason. 1984. Im- 
munoenzymatic labelling of monoclonal antibodies using im- 
mune complexes of  alkaline  phosphatase anti-alkaline  phospha- 
tase (APAAP).  J. Histochem. Cytochem. 32:219. 
7.  Patterson,  S., J. Gross, and A.D.B. Webster. 1989. DNA probes 
bind non-specifically  to eosinophils during in situ hybridiza- 
tion: carbol chromotrope blocks binding to eosinophils but 
does not inhibit hybridization to specific  nucleotide sequences. 
J.  Virol. Methods. 23:105. 
8.  Hoffman, A., 13. Banapeur, and J. Levy. 1985. Characteriza- 
tion of the AIDS-associated  retrovirus reverse transcriptase and 
optimal conditions  for its detection  in virions. Virology. 147:326. 
9.  Hansel, T.T., J.D. Pound, and R.A. Thompson. 1990. Isola- 
tion of eosinophils from human blood. J. Immunol. Methods. 
127:153. 
10.  Rothenberg, M.E., J. Petersen, and R.L. Stevens. 1989. 11.-5 
dependent conversion  of normodense human eosinophils  to the 
hypodense phenotype using 3T3 fibroblasts for enhanced via- 
bility, accelerated  hypodensity, and sustained antibody-depen- 
dent cytotoxicity. J. Immunol. 143:2311. 
11.  Fujisawa,  T., R. Abu-Ghazaleh, H. Kita, C.J. Sanderson, and 
G.J. Gleich. 1990. Regulatory effect of cytokines on eosino- 
phil degranulation. J. Immunol. 144:642. 
12.  Griffin,  G.E., K. Leung, T.M. Folks, S. Kunkel, and G.J. Nabel. 
1989. Activation of HIV gent expression during monocyte 
differentiation by induction of NF-IcB. Nature (Lond.). 339:70. 
13.  Stevenson,  M., X. Zhang, and D.J. Volsky. 1987. Downregu- 
lation of  cell surface molecules  during noncytopathic infection 
ofT cells with human immunodeficiency  virus.J. Virol. 61:3741. 
14.  Folks, T.M., S.W. Kessler,  J.M. Orenstein, J.S. Justement, E.S. 
Jaffe, and A.S. Fauci. 1988. Infection and replication of HIV-1 
in purified progenitor cells of normal human bone marrow. 
Science (Wash. DC). 242:919. 
15.  Kitano, K.,  C.N.  Abboud,  D.H.  Ryan,  S.G. Quan,  G.C. 
Baldwin, and D.W. Golde. 1991. Macrophage-active  colony- 
stimulating factors enhance human immunodeficiency virus 
type 1 infection in bone marrow stem cells. Blood. 77:1699, 
16.  Cordonnier,  A., L. Montagnier,  and M. Emerman. 1989. Single 
amino acid changes in HIV envelope affect viral tropism and 
receptor binding. Nature (Lond.). 340:571. 
17.  Sakaguchi,  M., T. Sato, andJ.E. Groopman. 1991. Human im- 
munodeficiency  virus infection of megakaryocytic  cells. Blood. 
77:481. 
18.  Weller,  P.F. 1991. The immunobiology ofeosinophils. N. Engl. 
J. Ailed. 324:1110. 
1664  Human  Immunodeficiency  Virus Infection  of Eosinophils 